Zubida Al-Majdoub

Zubida Al-Majdoub is a Research Fellow at The University of Manchester, affiliated with the Centre for Applied Pharmacokinetic Research (CAPKR) - a collaboration between academic researchers and nine industrial pharmaceutical companies. Her work bridges pharmacology, pharmaco-omics, and translational research through advanced quantitative proteomics and transcriptomics methodologies.

Research interests focus on drug metabolism, transporter quantification, and pharmacokinetic modeling, with particular emphasis on blood-brain barrier dynamics and liquid biopsy technologies. She has pioneered exosome isolation from plasma for diagnostic/prognostic biomarker development, while maintaining strong industry/regulatory collaborations.

Recent publications demonstrate expertise in multi-organ proteomics (liver, kidney, brain, placenta), in vitro-in vivo extrapolation, and precision dosing applications. Key innovations include QconCAT technology for protein quantification and LC-MS/MS workflows for drug target identification.

Current CAPKR research activities incorporate physiologically based pharmacokinetic modeling, NFκB pathway modulation, and ABC transporter quantification across biological systems. She actively employs mass spectrometry imaging and systems pharmacology approaches to address real-world drug development challenges.